Skip to main content
. 2021 Feb 11;39(1):35–43. doi: 10.1080/02813432.2021.1880123

Table 2.

Recommendations from International Guidelines and Finnish National Guidelines considering the usage of nasal saline irrigation (NSI) for different sinonasal diseases and the strength of recommendation (if reported).

Indication Recommendation Strength of recommendation
Acute rhinosinusitis and common cold (ARS)
 EPOS 2020 for adults and children [1] NSI possibly has benefits for symptom relief mainly in children Ib#
 EPOS 2020 for adults with acute post-viral rhinosinusitis [1] No recommendation can be given based on very low quality of evidence
 EPOS 2020 for adults with acute bacterial rhinosinusitis [1] No recommendation can be given based on very low quality of evidence
 Finnish Guideline: ARS and common cold [11] No mention of NSI
Allergic rhinitis (AR)
 ARIA 2008 [3] Recommended in a pharmacy setting
 Finnish guideline: AR [12] No mention of NSI  
 AAFP Clinical Practice Guideline: AR 2015 [13] No mention of NSI  
Asthma
 Global initiative for asthma (GINA) [14] No mention of NSI  
 Finnish guideline: Asthma [15] No mention of NSI  
 International ERS/ATS guideline for asthma [16] No mention of NSI  
Atrophic rhinitis
 Finnish guideline: Atrophic rhinitis [17] Recommended
Chronic sinusitis (CRS)
 EPOS 2020 for adults with chronic rhinosinusitis [1] Recommended Ia*
 EPOS 2020 for children with chronic rhinosinusitis [1] Recommended Ib+#
 Finnish guideline: CRS [11]* Recommended Low
Post-operative care after functional endoscopic sinus surgery (FESS)
 No official guidelines exist
Regular cleaning after FESS
 No official guidelines exist

Note. EPOS 2020 reports the level of evidence instead of strength of recommendation.

*Based on older Cochrane reviews, *Ia: based on systematic review of RCTs; #Ib: based on individual RCT.